West Pharmaceutical Services, Inc.
DE ˙ DB ˙ GB00BLGXWY71
269,50 € ↑3,00 (1,13%)
2026-06-04
AKTIENPREIS
SecurityDE:WPS / West Pharmaceutical Services, Inc.
InstitutionCommonwealth Equity Services, Llc
Latest Disclosed Ownership4,399 shares
Latest Disclosed Value $ 1,210,355
Commonwealth Equity Services, Llc reports 5.11% decrease in ownership of WPS / West Pharmaceutical Services, Inc.

On February 12, 2026 - Commonwealth Equity Services, Llc filed a 13F-HR form disclosing ownership of 4,399 shares of West Pharmaceutical Services, Inc. (DE:WPS) valued at $1,021,008 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 22, 2025 disclosing 4,636 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of -5.11% during the quarter. The current value of the position is $1,185,530 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-12 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,399 -237 -5.11 1,210 120,900.00 0.0016
2025-10-22 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,636 -74 -1.57 1 0.00 0.0016
2025-08-06 2025-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,710 -296 -5.91 1 0.00 0.0014
2025-05-09 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,006 475 10.48 1 0.00 0.0016
2025-02-10 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,531 -512 -10.15 1 0.00 0.0022
2024-10-18 2024-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,043 -913 -15.33 2 0.00 0.0023
2024-07-31 2024-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,956 -343 -5.45 2 -50.00 0.0031
2024-04-29 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 6,299 -52 -0.82 2 0.00 0.0041
2024-02-06 2023-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 6,351 -89 -1.38 2 0.00 0.0041
2023-10-23 2023-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 6,440 58 0.91 2 0.00 0.0050
2023-08-10 2023-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 6,382 -1,739 -21.41 2 0.00 0.0050
2023-05-11 2023-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 8,121 -822 -9.19 3 0.00 0.0059
2023-02-07 2022-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 8,943 -815 -8.35 2 -99.92 0.0051
2022-11-14 2022-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 9,758 287 3.03 2,401 -16.17 0.0062
2022-07-19 2022-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 9,471 -94 -0.98 2,864 -27.09 0.0075
2022-05-04 2022-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 9,565 -5,015 -34.40 3,928 -42.56 0.0090
2022-01-31 2021-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 14,580 1,530 11.72 6,838 23.43 0.0154
2021-10-29 2021-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 13,050 2,321 21.63 5,540 43.78 0.0139
2021-08-11 2021-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 10,729 5,378 100.50 3,853 155.67 0.0098
2021-05-04 2021-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,351 -417 -7.23 1,507 -7.77 0.0043
2021-02-11 2020-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 5,768 917 18.90 1,634 22.58 0.0049
2020-11-05 2020-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,851 -123 -2.47 1,333 17.96 0.0046
2020-08-12 2020-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 4,974 1,335 36.69 1,130 103.97 0.0043
2020-05-11 2020-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,639 -146 -3.86 554 -2.64 0.0026
2020-02-05 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,785 120 3.27 569 9.63 0.0022
2019-10-30 2019-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,665 -66 -1.77 519 11.37 0.0022
2019-07-19 2019-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,731 25 0.67 466 14.22 0.0021
2019-05-13 2019-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,706 -150 -3.89 408 7.94 0.0019
2019-02-11 2018-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,856 208 5.70 378 -16.00 0.0020
2018-11-06 2018-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 3,648 1,220 50.25 450 86.72 0.0022
2018-07-31 2018-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,428 -193 -7.36 241 4.33 0.0013
2018-05-14 2018-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,621 -184 -6.56 231 -16.61 0.0013
2018-02-12 2017-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 2,805 2,805 277 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.